Akebia Therapeutics Inc.

(AKBA) Trade

By |

Profile

Akebia Therapeutics Inc is a biopharmaceutical company. It focuses on the development and commercialization of novel therapeutics to patients with kidney disease through hypoxia-inducible factor (HIF) biology.

Contact Information

Website: www.akebia.com
Email: david@argotpartners.com
Main Phone: +1 617 871-2098
Address: 245 First Street
Address 2: Suite 1100
State: MA
City / Town: Cambridge
Country: USA
Postal Code: 02142

Issuer Information

Exchange: NSD
CEO: John P. Butler
Employees: 114
NAICS: Pharmaceutical Preparation Manufacturing(325412)
$ 8.72 $ 0.16 (1.87%)
Last Price 8.72 Change $ 0.16 Change % 1.87 Tick N/A
Bid 7.81 Bid Size 100.00 Ask 9.09 Ask Size 1,000.00
Open 8.66 High 8.91 Low 8.42 Prev Close 8.56
Last Trade Volume 423,562 52 Wk Hi 18.78 52 Wk Low 7.32
Market Cap 497.4 mi Ex-Div Date N/A Div Rate N/A Yield N/A
Shares 57,046,563.00 EPS (TTM) -1.23 PE Ratio N/A Exchange NSD
  Last 3 Mo Last 12 Mo
Number of Insider Trades 0 11
Number of Buys 0 1
Number of Sells 0 10
Net Activity 0 1009150
Last 10 Buys Shares
Muneer A. Satter 1,000
Muneer A. Satter 1,000
John P. Butler 1,000
John P. Butler 1,000
Jason A. Amello 1,000
Muneer A. Satter 1,000
Muneer A. Satter 1,000
Muneer A. Satter 1,000
Muneer A. Satter 1,000
Muneer A. Satter 1,000
Last 10 Sell Shares
Duane D. Nash 1,000
Nicole R. Hadas 1,000
Nicole R. Hadas 1,000
Michel Dahan 1,000
Duane D. Nash 1,000
Michel Dahan 1,000
Michel Dahan 1,000
Nicole R. Hadas 1,000
Michel Dahan 1,000
Duane D. Nash 1,000
  Current 1 Week Ago 2 Weeks Ago 3 Weeks Ago
High Target Price Estimate 30 30 30 30
Low Target Price Estimate 17 17 17 17
Mean Target Price Estimate 23.2 23.6 23.6 23.2
Standard Deviation 4.66 4.62 4.62 4.66
Date of Most Recent Estimate 06/06/18 05/09/18 05/09/18 06/06/18
  Current 1 Month Ago 2 Months Ago 3 Months Ago
Strong Buy 4 4 4 4
Moderate Buy 0 0 2 2
Hold 1 1 1 1
Moderate Sell 0 0 0 0
Strong Sell 0 0 0 0
Mean Rec. 1.4 1.4 1.5 1.5